529 related articles for article (PubMed ID: 16896134)
1. Triclabendazole and its two main metabolites lack activity against Schistosoma mansoni in the mouse model.
Keiser J; El Ela NA; El Komy E; El Lakkany N; Diab T; Chollet J; Utzinger J; Barakat R
Am J Trop Med Hyg; 2006 Aug; 75(2):287-91. PubMed ID: 16896134
[TBL] [Abstract][Full Text] [Related]
2. Lack of evidence for an antischistosomal activity of myrrh in experimental animals.
Botros S; William S; Ebeid F; Cioli D; Katz N; Day TA; Bennett JL
Am J Trop Med Hyg; 2004 Aug; 71(2):206-10. PubMed ID: 15306712
[TBL] [Abstract][Full Text] [Related]
3. Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro.
Keiser J; Manneck T; Vargas M
J Antimicrob Chemother; 2011 Aug; 66(8):1791-7. PubMed ID: 21602552
[TBL] [Abstract][Full Text] [Related]
4. In vivo effect of single oral dose of artemether against early juvenile stages of Schistosoma mansoni Egyptian strain.
El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
Exp Parasitol; 2013 Oct; 135(2):240-5. PubMed ID: 23876575
[TBL] [Abstract][Full Text] [Related]
5. On the schistosomicidal effect of triclabendazole an experimental study.
Khalil SS
J Egypt Soc Parasitol; 2000 Dec; 30(3):799-808. PubMed ID: 11198378
[TBL] [Abstract][Full Text] [Related]
6. Schistosomicidal activity of the antimalarial drug, mefloquine, in Schistosoma mansoni-infected mice.
Van Nassauw L; Toovey S; Van Op den Bosch J; Timmermans JP; Vercruysse J
Travel Med Infect Dis; 2008 Sep; 6(5):253-8. PubMed ID: 18760248
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic effect of subcurative dose praziquantel on Schistosoma mansoni infected mice and resistance to challenge infection after treatment.
Chaiworaporn R; Maneerat Y; Rojekittikhun W; Ramasoota P; Janecharut T; Matsuda H; Kitikoon V
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):846-52. PubMed ID: 16295535
[TBL] [Abstract][Full Text] [Related]
8. Anthelmintic activity in vitro and in vivo of Baccharis trimera (Less) DC against immature and adult worms of Schistosoma mansoni.
de Oliveira RN; Rehder VL; Oliveira AS; Jeraldo Vde L; Linhares AX; Allegretti SM
Exp Parasitol; 2014 Apr; 139():63-72. PubMed ID: 24602876
[TBL] [Abstract][Full Text] [Related]
9. Effect of artemether administered alone or in combination with praziquantel to mice infected with Plasmodium berghei or Schistosoma mansoni or both.
Shu-Hua X; Utzinger J; Chollet J; Tanner M
Int J Parasitol; 2006 Jul; 36(8):957-64. PubMed ID: 16750833
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of oral therapy on Mansonial Schistosomiasis using single dose of Balanites aegyptiaca fruits and praziquantel.
Koko WS; Abdalla HS; Galal M; Khalid HS
Fitoterapia; 2005 Jan; 76(1):30-4. PubMed ID: 15664459
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of a Brazilian wild rodent isolate of Schistosoma mansoni to praziquantel in mice.
Costa-Silva M; Barros Lde A; Garcia JS; Neves RH; Rodrigues-Silva R; Machado-Silva JR; Maldonado-Júnior A
Exp Parasitol; 2012 Apr; 130(4):394-9. PubMed ID: 22343042
[TBL] [Abstract][Full Text] [Related]
12. Schistosoma mansoni: maturation rate and drug susceptibility of different geographic isolates.
Fallon PG; Mubarak JS; Fookes RE; Niang M; Butterworth AE; Sturrock RF; Doenhoff MJ
Exp Parasitol; 1997 May; 86(1):29-36. PubMed ID: 9149238
[TBL] [Abstract][Full Text] [Related]
13. First insight into the effect of single oral dose therapy with artemisinin-naphthoquine phosphate combination in a mouse model of Schistosoma mansoni infection.
El-Beshbishi SN; Taman A; El-Malky M; Azab MS; El-Hawary AK; El-Tantawy DA
Int J Parasitol; 2013 Jun; 43(7):521-30. PubMed ID: 23500074
[TBL] [Abstract][Full Text] [Related]
14. Effect of artemether on Schistosoma mansoni: dose-efficacy relationship, and changes in worm morphology and histopathology.
Xiao SH; Guo J; Chollet J; Wu JT; Tanner M; Utzinger J
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Jun; 22(3):148-53. PubMed ID: 15597709
[TBL] [Abstract][Full Text] [Related]
15. Host-parasite relationships in infections with two Kenyan isolates of Schistosoma mansoni in NMRI mice.
Thiongo FW; Madsen H; Ouma JH; Andreassen J; Christensen NO
J Parasitol; 1997 Apr; 83(2):330-2. PubMed ID: 9105324
[TBL] [Abstract][Full Text] [Related]
16. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni: In vivo evaluation of Phyllanthus amarus hexanic and ethanolic extracts.
de Oliveira CNF; Frezza TF; Garcia VL; Figueira GM; Mendes TMF; Allegretti SM
Exp Parasitol; 2017 Dec; 183():56-63. PubMed ID: 29074138
[TBL] [Abstract][Full Text] [Related]
18. Antischistosomal and liver protective effects of Curcuma longa extract in Schistosoma mansoni infected mice.
El-Ansary AK; Ahmed SA; Aly SA
Indian J Exp Biol; 2007 Sep; 45(9):791-801. PubMed ID: 17907745
[TBL] [Abstract][Full Text] [Related]
19. Effect of two trematodicidal drugs on the morphology and tegumentary ultrastructure of Schistosoma mansoni.
Mansoury ST
J Egypt Soc Parasitol; 1997 Apr; 27(1):233-41. PubMed ID: 9097545
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of Schistosoma mansoni prevalent in Saudi Arabia to oxamniquine in experimentally infected mice.
Amin AM; Mikhail EG
J Trop Med Hyg; 1988 Aug; 91(4):192-5. PubMed ID: 3136251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
